Picture of CONCORD DRUGS logo

538965 CONCORD DRUGS Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for CONCORD DRUGS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2018
March 31st
2019
March 31st
C2020
March 31st
2021
March 31st
2022
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line6.394.44.5742.922.5
Depreciation
Non-Cash Items17.914.914.412.414
Other Non-Cash Items
Changes in Working Capital20.5-24.5-8.75-52.8-46.4
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities68.811.924.816.27.74
Capital Expenditures-22.8-3.4-8.48-36.7-0
Purchase of Fixed Assets
Other Investing Cash Flow Items0.639-0.0390.080.0810.123
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-22.1-3.44-8.4-36.70.122
Financing Cash Flow Items-47.418.6-24.1-13.3-17.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-48-7.32-17.920.716.8
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1.311.18-1.470.23424.7

Or unlock with your email

Or unlock with your email